MDxHealth S.A. operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares MDxHealth S.A. with three other
miscellaneous service companies in Europe:
sales of 10.63 million Euros [US$12.54 million]
of which 92%
of UNITED KINGDOM
(£9.29 million [US$12.13 million]
Evolva Holding SA
based in SWITZERLAND
(11.60 million Swiss Francs [US$12.70 million]
of which 100%
was Novel Food Nutritional & Pharmaceutical).
MDxHealth S.A. reported sales of 10.54 million Euro (US$12.43 million)
December of 2019.
decrease of 56.3%
versus 2018, when the company's sales were 24.10 million Euro.